Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel. more
Time Frame | CLGN | Sector | S&P500 |
---|---|---|---|
1-Week Return | -14.05% | 0.31% | -1.26% |
1-Month Return | 6.08% | 0.6% | -4.16% |
3-Month Return | -17.62% | -9.44% | -0.46% |
6-Month Return | -24.03% | -5.15% | 3.58% |
1-Year Return | -33.15% | 0.33% | 22.47% |
3-Year Return | -67.17% | 4.53% | 25.13% |
5-Year Return | -63.39% | 35.98% | 77.7% |
10-Year Return | -79.18% | 100.72% | 190.12% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 2.32M | 6.14M | 15.64M | 299.00K | 10.96M | [{"date":"2019-12-31","value":14.82,"profit":true},{"date":"2020-12-31","value":39.24,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":1.91,"profit":true},{"date":"2023-12-31","value":70.07,"profit":true}] |
Cost of Revenue | 1.88M | 3.00M | 2.00M | 400.00K | 1.99M | [{"date":"2019-12-31","value":62.59,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":66.79,"profit":true},{"date":"2022-12-31","value":13.32,"profit":true},{"date":"2023-12-31","value":66.32,"profit":true}] |
Gross Profit | 439.00K | 3.13M | 13.64M | (101.00K) | 8.97M | [{"date":"2019-12-31","value":3.22,"profit":true},{"date":"2020-12-31","value":22.99,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-0.74,"profit":false},{"date":"2023-12-31","value":65.77,"profit":true}] |
Gross Margin | 18.94% | 51.08% | 87.18% | (33.78%) | 81.83% | [{"date":"2019-12-31","value":21.72,"profit":true},{"date":"2020-12-31","value":58.59,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-38.75,"profit":false},{"date":"2023-12-31","value":93.86,"profit":true}] |
Operating Expenses | 8.07M | 8.73M | 13.57M | 17.00M | 16.48M | [{"date":"2019-12-31","value":47.48,"profit":true},{"date":"2020-12-31","value":51.39,"profit":true},{"date":"2021-12-31","value":79.85,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.96,"profit":true}] |
Operating Income | (7.63M) | (5.60M) | 65.00K | (17.10M) | (7.51M) | [{"date":"2019-12-31","value":-11740,"profit":false},{"date":"2020-12-31","value":-8613.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-26303.08,"profit":false},{"date":"2023-12-31","value":-11556.92,"profit":false}] |
Total Non-Operating Income/Expense | (3.61M) | (169.00K) | 354.00K | 344.00K | 997.00K | [{"date":"2019-12-31","value":-361.69,"profit":false},{"date":"2020-12-31","value":-16.95,"profit":false},{"date":"2021-12-31","value":35.51,"profit":true},{"date":"2022-12-31","value":34.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (11.16M) | (5.77M) | 237.00K | (16.93M) | (7.02M) | [{"date":"2019-12-31","value":-4710.55,"profit":false},{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2961.6,"profit":false}] |
Income Taxes | 3.53M | 34.00K | (172.00K) | (172.00K) | (1.00) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":0.96,"profit":true},{"date":"2021-12-31","value":-4.87,"profit":false},{"date":"2022-12-31","value":-4.87,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
Income After Taxes | (14.70M) | (5.81M) | 409.00K | (16.75M) | (7.02M) | [{"date":"2019-12-31","value":-3593.4,"profit":false},{"date":"2020-12-31","value":-1420.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4096.09,"profit":false},{"date":"2023-12-31","value":-1716.14,"profit":false}] |
Income From Continuous Operations | (11.16M) | (5.77M) | 237.00K | (16.93M) | (6.73M) | [{"date":"2019-12-31","value":-4710.55,"profit":false},{"date":"2020-12-31","value":-2436.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-7141.35,"profit":false},{"date":"2023-12-31","value":-2840.08,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (14.70M) | (5.81M) | 409.00K | (16.75M) | (7.02M) | [{"date":"2019-12-31","value":-3593.4,"profit":false},{"date":"2020-12-31","value":-1420.05,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-4096.09,"profit":false},{"date":"2023-12-31","value":-1716.14,"profit":false}] |
EPS (Diluted) | (2.46) | (0.79) | (0.01) | (1.53) | (0.46) | [{"date":"2019-12-31","value":-246.45,"profit":false},{"date":"2020-12-31","value":-79,"profit":false},{"date":"2021-12-31","value":-1,"profit":false},{"date":"2022-12-31","value":-153,"profit":false},{"date":"2023-12-31","value":-46,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CLGN | |
---|---|
Cash Ratio | 5.01 |
Current Ratio | 5.38 |
Quick Ratio | 5.23 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CLGN | |
---|---|
ROA (LTM) | -33.77% |
ROE (LTM) | -61.55% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CLGN | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.25 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.75 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CLGN | |
---|---|
Trailing PE | NM |
Forward PE | 15.55 |
P/S (TTM) | 63.90 |
P/B | 2.66 |
Price/FCF | NM |
EV/R | 50.58 |
EV/Ebitda | NM |
Collplant Biotechnologies Ltd (CLGN) share price today is $3.8439
Yes, Indians can buy shares of Collplant Biotechnologies Ltd (CLGN) on Vested. To buy Collplant Biotechnologies Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CLGN stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Collplant Biotechnologies Ltd (CLGN) via the Vested app. You can start investing in Collplant Biotechnologies Ltd (CLGN) with a minimum investment of $1.
You can invest in shares of Collplant Biotechnologies Ltd (CLGN) via Vested in three simple steps:
The 52-week high price of Collplant Biotechnologies Ltd (CLGN) is $6.75. The 52-week low price of Collplant Biotechnologies Ltd (CLGN) is $3.24.
The price-to-earnings (P/E) ratio of Collplant Biotechnologies Ltd (CLGN) is
The price-to-book (P/B) ratio of Collplant Biotechnologies Ltd (CLGN) is 2.66
The dividend yield of Collplant Biotechnologies Ltd (CLGN) is 0.00%
The market capitalization of Collplant Biotechnologies Ltd (CLGN) is $44.03M
The stock symbol (or ticker) of Collplant Biotechnologies Ltd is CLGN